ArticleBioinformatics (Oxford, England)2026
GlycanGT: a pretrained graph transformer framework for glycan graph representation and generative learning.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Understanding glycan structure and function through artificial intelligence.BBA advances · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
motivationGlycans are highly diverse biological sequences, but their functional understanding has lagged behind proteins and nucleic acids. Many glycans remain ambiguously annotated, limiting computational analyses. Existing computational approaches are primarily graph-based, capturing local structural features but struggling to model global patterns and incomplete sequences.
resultsWe present GlycanGT, a graph-transformer-based pretrained model for glycans. Glycans were represented as graphs of monosaccharides and glycosidic bonds, and the model was pretrained using a masked language modeling objective. GlycanGT demonstrated higher performance than existing methods across 8 benchmark tasks (e.g., 0.844 AUPRC for immunogenicity classification), and its embeddings formed biologically relevant clusters that recovered known N- and O-glycan categories. Moreover, GlycanGT accurately proposed candidates for ambiguous sequences, maintaining >80% top-5 accuracy for both monosaccharide and glycosidic bond predictions under high masking levels. AVAILABILITY AND IMPLEMENTATION: The source code used in this study is available at https://github.com/matsui-lab/GlycanGT and archived on Zenodo (DOI: 10.5281/zenodo.18636040); pretrained model weights are provided via Hugging Face (https://huggingface.co/Akikitani295/GlycanGT). CONTACT: matsui.yusuke.d4@f.mail.nagoya-u.ac.jp. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.